TTK Healthcare Limited

NSE TTKHLTCARE.NS

TTK Healthcare Limited Return on Equity (ROE) for the year ending March 31, 2024: 6.28%

TTK Healthcare Limited Return on Equity (ROE) is 6.28% for the year ending March 31, 2024, a -90.64% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • TTK Healthcare Limited Return on Equity (ROE) for the year ending March 31, 2023 was 67.10%, a 431.83% change year over year.
  • TTK Healthcare Limited Return on Equity (ROE) for the year ending March 31, 2022 was 12.62%, a -19.95% change year over year.
  • TTK Healthcare Limited Return on Equity (ROE) for the year ending March 31, 2021 was 15.76%, a 218.57% change year over year.
  • TTK Healthcare Limited Return on Equity (ROE) for the year ending March 31, 2020 was 4.95%, a -48.96% change year over year.
Key data
Date Return on Equity (ROE) Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio
Market news
Loading...
SV Wall Street
NSE: TTKHLTCARE.NS

TTK Healthcare Limited

CEO Mr. S. Kalyanaraman
IPO Date Jan. 8, 2010
Location India
Headquarters No.6, Cathedral Road
Employees 1,316
Sector Consumers Staples
Industries
Description

TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, and food businesses in India and internationally. Its Animal Welfare segment deals in various therapeutic formulations and feed supplements for veterinary use. The company's Consumer Products segment is involved in the marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, Good Home range of scrubbers, air fresheners, etc. its Medical Devices segment manufactures and distributes artificial heart valves; and develops orthopedic implants and instruments. The company's Protective Devices segment manufactures and markets male contraceptives and other allied products. Its Foods segment engages in the manufacturing and marketing of food products, including potato and cereal based pellets. The company's Others segment prints and publishes maps and atlases. Its Human Pharma segment deals in herbal and allopathic formulations for human use. The company was incorporated in 1958 and is headquartered in Chennai, India. TTK Healthcare Limited is a subsidiary of TT Krishnamachari & Co., Ltd.

Similar companies

THEMISMED.NS

Themis Medicare Limited

USD 2.62

1.36%

RPGLIFE.NS

RPG Life Sciences Limited

USD 28.13

1.29%

UNICHEMLAB.NS

Unichem Laboratories Limited

USD 8.15

-0.17%

AMRUTANJAN.NS

Amrutanjan Health Care Limited

USD 7.68

-0.02%

HESTERBIO.NS

Hester Biosciences Limited

USD 22.57

-4.38%

StockViz Staff

February 2, 2025

Any question? Send us an email